Intelligent Bio Solutions Inc.
INBS
$2.47
$0.041.65%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.22M | 3.91M | 3.58M | 3.29M | 3.05M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.22M | 3.91M | 3.58M | 3.29M | 3.05M |
| Cost of Revenue | 2.17M | 2.06M | 1.93M | 1.87M | 1.81M |
| Gross Profit | 2.05M | 1.85M | 1.66M | 1.42M | 1.25M |
| SG&A Expenses | 10.45M | 10.18M | 10.13M | 9.61M | 8.90M |
| Depreciation & Amortization | 1.16M | 1.18M | 1.19M | 1.21M | 1.21M |
| Other Operating Expenses | -677.80K | -815.60K | -823.20K | -884.10K | -816.90K |
| Total Operating Expenses | 16.47M | 15.09M | 14.37M | 13.74M | 13.49M |
| Operating Income | -12.25M | -11.17M | -10.79M | -10.45M | -10.44M |
| Income Before Tax | -12.47M | -11.65M | -11.33M | -10.91M | -10.60M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.47 | -11.65 | -11.33 | -10.91 | -10.60 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 37.70K | 40.40K | 40.60K | 38.90K | 36.10K |
| Net Income | -12.43M | -11.61M | -11.29M | -10.87M | -10.57M |
| EBIT | -12.25M | -11.17M | -10.79M | -10.45M | -10.44M |
| EBITDA | -11.09M | -10.20M | -9.84M | -9.46M | -9.46M |
| EPS Basic | -9.66 | -12.52 | -15.13 | -17.27 | -20.83 |
| Normalized Basic EPS | -5.82 | -7.40 | -9.03 | -10.38 | -12.79 |
| EPS Diluted | -9.66 | -12.52 | -15.13 | -17.27 | -20.83 |
| Normalized Diluted EPS | -5.82 | -7.40 | -9.03 | -10.38 | -12.79 |
| Average Basic Shares Outstanding | 5.90M | 4.10M | 3.08M | 2.59M | 2.11M |
| Average Diluted Shares Outstanding | 5.90M | 4.10M | 3.08M | 2.59M | 2.11M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |